A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sharps Technology Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 136,865 shares of STSS stock, worth $257,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,865
Holding current value
$257,306
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.15 - $0.31 $20,529 - $42,428
136,865 New
136,865 $20,000
Q4 2023

Feb 13, 2024

BUY
$0.39 - $0.54 $13,884 - $19,224
35,600 New
35,600 $15,000
Q4 2022

Feb 13, 2023

SELL
$1.0 - $1.37 $12,266 - $16,804
-12,266 Reduced 28.74%
30,418 $37,000
Q3 2022

Nov 14, 2022

BUY
$0.92 - $1.45 $39,269 - $61,891
42,684 New
42,684 $49,000

Others Institutions Holding STSS

About Sharps Technology Inc.


  • Ticker STSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 9,207,420
  • Market Cap $17.3M
  • Description
  • Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in...
More about STSS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.